Saakshi Khattri, MD, recounts the evolution of treatments for atopic dermatitis (AD), from the widespread use of general immune suppressants such as methotrexate and cyclosporine, to more recent, targeted agents such as dupilumab and tralokinumab.
This steady stream of approved agents, Dr Khattri contends, has allowed for greater refinement in therapeutic approach and an enhanced focus in the treatment of this debilitating disease.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Management of Atopic Dermatitis: Bringing Therapy Into Focus - Medscape - Jun 29, 2022.